Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study

Proteasome inhibitor therapy for antibody-mediated rejection

(2015) E. S. Woodle et al.   PEDIATRIC TRANSPLANTATION

Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation

(2012) F. Paterno et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma

(2012) Grit Hutter et al.   ANNALS OF HEMATOLOGY

The 39th David A. Karnofsky Lecture: Bench-to-Bedside Translation of Targeted Therapies in Multiple Myeloma

(2012) Kenneth C. Anderson   JOURNAL OF CLINICAL ONCOLOGY

Proteasome inhibitor-based therapy for antibody-mediated rejection

(2012) R. Carlin Walsh et al.   KIDNEY INTERNATIONAL

Proteasome inhibition by bortezomib: Effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation

(2012) Martina Guthoff et al.   TRANSPLANT IMMUNOLOGY

Prospective Evaluation of the Toxicity Profile of Proteasome Inhibitor–Based Therapy in Renal Transplant Candidates and Recipients

(2012) Nicole Schmidt et al.   TRANSPLANTATION

Human CD55 Expression Blocks Hyperacute Rejection and Restricts Complement Activation in Gal Knockout Cardiac Xenografts

(2012) Christopher G.A. McGregor et al.   TRANSPLANTATION

T-Cell-Based Immunosuppressive Therapy Inhibits the Development of Natural Antibodies in Infant Baboons

(2012) Eefje M. Dons et al.   TRANSPLANTATION

Abrogation of Antibodies Improves Outcome of Renal Transplantation

(2012) H.L. Trivedi et al.   TRANSPLANTATION PROCEEDINGS

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

(2011) K. Neben et al.   BLOOD

Proteasome inhibitor treatment of antibody-mediated allograft rejection

(2011) E. Steve Woodle et al.   Current Opinion in Organ Transplantation

Clinical and investigational use of proteasome inhibitors for transplant rejection

(2011) Basma Sadaka et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

(2011) Benjamin Besse et al.   LUNG CANCER

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection

(2011) J. Waiser et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The state of therapy for removal of alloantibody producing plasma cells in transplantation

(2011) Matthew J. Everly et al.   SEMINARS IN IMMUNOLOGY

The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo

(2011) Tayyab S. Diwan et al.   TRANSPLANTATION

Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients

(2011) William Robert Morrow et al.   TRANSPLANTATION

What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?

(2011) E. Scott et al.   Hematology-American Society of Hematology Education Program

Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies

(2010) R. Sberro-Soussan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition

(2010) Matthew J. Everly et al.   TRANSPLANTATION

Effect of the Proteasome Inhibitor Bortezomib on Humoral Immunity in Two Presensitized Renal Transplant Candidates

(2010) Markus Wahrmann et al.   TRANSPLANTATION

Clonal Deletion With Bortezomib Followed by Low or No Maintenance Immunosuppression in Renal Allograft Recipients

(2010) Hargovind L. Trivedi et al.   TRANSPLANTATION

Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

(2010) R Carlin Walsh et al.   TRANSPLANTATION

The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation

(2010) Stuart M. Flechner et al.   TRANSPLANTATION

Role of complement regulatory protein expression and CD154 blockade in Gal-independent xenograft rejection

(2010) A. M. Azimzadeh et al.   XENOTRANSPLANTATION

Investigation of potential carbohydrate antigen targets for human and baboon antibodies

(2010) Peter Yeh et al.   XENOTRANSPLANTATION

The vascular and coagulation issues in xenotransplantation

(2009) Peter J Cowan et al.   Current Opinion in Organ Transplantation

Proteasome inhibition for antibody-mediated rejection

(2009) Jason J Everly et al.   Current Opinion in Organ Transplantation

The Innate Immune Response and Activation of Coagulation in α1,3-Galactosyltransferase Gene-Knockout Xenograft Recipients

(2009) Mohamed Ezzelarab et al.   TRANSPLANTATION

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition

(2009) Hargovind L. Trivedi et al.   TRANSPLANTATION

Thrombotic Microangiopathy Associated with Humoral Rejection of Cardiac Xenografts from α1,3-Galactosyltransferase Gene-Knockout Pigs in Baboons

(2008) Akira Shimizu et al.   AMERICAN JOURNAL OF PATHOLOGY

Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production

(2008) D. K. Perry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

(2008) Matthew J. Everly et al.   TRANSPLANTATION